| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, NE 68178; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333
* To whom correspondence should be addressed. Email:
rgoering{at}creighton.edu.
Recent reports have noted a discernible increase in the number of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in patients without traditional risk factors. In the United States, the most prominent CA-MRSA strain encodes Panton-Valentine Leukocidin (PVL) cytotoxin genes, belongs to pulsed field gel electrophoresis (PFGE) type USA300, multi-locus sequence type 8 (ST8), and carries staphylococcal cassette chromosome mec type IV. At present, molecular characterization of MRSA such as USA300 can be time consuming and is often beyond the technical capability of many clinical laboratories, making routine identification difficult. We analyzed the chromosomal regions flanking the SCCmec element in 44 USA300 MRSA isolates and identified a signature AT repeat sequence within the conserved hypothetical gene SACOL0058 located 1.4 kb downstream of the 3' end of the J1 SCCmec-chromosomal junction. Only USA300 isolates tested contained a sequence of
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
Rapid Multiplex PCR Assay for Identification of USA300 Community-Associated Methicillin-Resistant Staphylococcus aureus Isolates
![]()
Abstract
6 AT repeats in combination with PVL (e.g., related USA500 or Iberian strains had
6 AT repeats but were PVL negative). Using a locked nucleic acid (LNA) primer specific for
6 AT repeats in combination with primers to detect PVL, we developed a multiplex PCR assay specific for the identification of USA300 strains. Multiplex results were 100% concordant with DNA sequencing, suggesting the method has promise as a means of rapidly identifying USA300 isolates.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|